TRIATHALONBIKE

Tuesday, August 16, 2005

Biophan Outlines Recent Activities in SEC Form 10-Q for Quarter Ended 5/31/2005

Biophan Technologies, a developer of next-generation biomedical technology, has released additional details of its recently executed technology licensing agreement with medical device manufacturer Boston Scientific in its SEC Form 10-Q =6;} else if(navigator.userAgent && navigator.userAgent.toLowerCase.indexOf >=0 && (navigator.userAgent.indexOf >=0 || navigator.userAgent.indexOf >=0 || navigator.userAgent.indexOf >=0)) {document.writeln ;document.writeln ;document.writeln('plugin=(IsObject(CreateObject ))');document.writeln ;} //> =4))){ var prs=ads.PointRoll.com/PRServe/?ad=989A5420055191619&pub=yhoofin&num=+prInst+&size=300_250&code=no&redir=+pr_redir+&defredir=+pr_redir_def+&bu=+pr_bust+&r=+Math.random ; document.write ; }else{ var prpx=new Image ;prpx.src='. more...

http://www.triathalonbike.com/floridatriathalon
Originally Posted on 16/08/2005 23:52:27Content source: http://www.myHealthcareNews.com/r.aspx?a=237233&d=

0 Comments:

Post a Comment

<< Home